产后因高血压和子痫前期再入院:预测模型的开发与验证
利用美国南部和东北部两个三级医疗系统共28201例产后个体的电子健康记录数据,开发并验证产后6周内因高血压或子痫前期再入院的预测模型。最终模型含六个变量,合并数据集建模后区分度良好(c统计量0.80),在1%至7%的临床决策阈值区间提供净获益。作者认为该再入院可能被准确预测,但需进一步验证和模型更新后方可跨临床环境使用。
要点
- 产后因高血压和子痫前期再入院总体发生率为0.9%,南部0.3%、东北部1.2%。
- 最终模型含年龄、产次、产后最大舒张压、出生体重、出院前子痫前期和分娩方式六个变量。
- 合并数据集新模型c统计量0.80,在1%至7%决策阈值区间净获益优于不行干预。
核心结论
- 产后因高血压和子痫前期再入院可能被准确预测,但需进一步模型验证。
- 在跨临床环境使用前,需利用多站点数据进行模型更新。
研究设计与样本
- 预测模型研究,使用来自两个临床站点的电子健康记录数据。
- 研究设置:美国南部(2014—2015年)和东北部(2017—2019年)两个三级医疗系统。
- 研究人群:共28201例产后个体,南部10100例,东北部18101例。
- 采用内部-外部交叉验证评估外部验证或模型可移植性;模型用惩罚逻辑回归拟合。
- 内部验证采用偏差校正性能指标的bootstrapping;用决策曲线分析显示净获益的潜在切点。
主要发现
- 产后因高血压和子痫前期再入院总体发生率为0.9%(南部0.3%,东北部1.2%)。
- 最终模型含六个变量:年龄、产次、产后最大舒张压、出生体重、出院前子痫前期和分娩方式(含子痫前期×分娩方式交互项)。
- 内部验证区分度:南部c统计量0.88(95%CI 0.87-0.89),东北部0.74(95%CI 0.74-0.74)。
- 内部-外部交叉验证中区分度不一致:东北部模型在南部队列c统计量0.61,南部模型在东北部队列0.86,但校准不充分。
- 合并数据集更新后的最终模型区分度良好(c统计量0.80,95%CI 0.80-0.80),校准中等(截距-0.153,斜率0.960,Emax 0.042),在1%至7%临床决策阈值区间对预防再入院的干预提供更优净获益。
临床怎么用
- 原文提供在线计算器。
- 作者认为该模型可能准确预测产后因高血压和子痫前期再入院,但需进一步模型验证。
- 作者指出在跨临床环境使用前需利用多站点数据进行模型更新。
局限性
- 内部-外部交叉验证中区分度不一致,且校准不充分。
- 作者结论指出需进一步模型验证。
- 作者指出在跨临床环境使用前需利用多站点数据进行模型更新。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop a model for predicting postpartum readmission for hypertension and pre-eclampsia at delivery discharge and assess external validation or model transportability across clinical sites. DESIGN: Prediction model using data available in the electronic health record from two clinical sites. SETTING: Two tertiary care health systems from the Southern (2014-2015) and Northeastern USA (2017-2019). POPULATION: A total of 28 201 postpartum individuals: 10 100 in the South and 18 101 in the Northeast. METHODS: An internal-external cross validation (IECV) approach was used to assess external validation or model transportability across the two sites. In IECV, data from each health system were first used to develop and internally validate a prediction model; each model was then externally validated using the other health system. Models were fit using penalised logistic regression, and accuracy was estimated using discrimination (concordance index), calibration curves and decision curves. Internal validation was performed using bootstrapping with bias-corrected performance measures. Decision curve analysis was used to display potential cut points where the model provided net benefit for clinical decision-making. MAIN OUTCOME MEASURES: The outcome was postpartum readmission for either hypertension or pre-eclampsia <6 weeks after delivery. RESULTS: The postpartum readmission rate for hypertension and pre-eclampsia overall was 0.9% (0.3% and 1.2% by site, respectively). The final model included six variables: age, parity, maximum postpartum diastolic blood pressure, birthweight, pre-eclampsia before discharge and delivery mode (and interaction between pre-eclampsia × delivery mode). Discrimination was adequate at both health systems on internal validation (c-statistic South: 0.88; 95% confidence interval [CI] 0.87-0.89; Northeast: 0.74; 95% CI 0.74-0.74). In IECV, discrimination was inconsistent across sites, with improved discrimination for the Northeastern model on the Southern cohort (c-statistic 0.61 and 0.86, respectively), but calibration was not adequate. Next, model updating was performed using the combined dataset to develop a new model. This final model had adequate discrimination (c-statistic: 0.80, 95% CI 0.80-0.80), moderate calibration (intercept -0.153, slope 0.960, Emax 0.042) and provided superior net benefit at clinical decision-making thresholds between 1% and 7% for interventions preventing readmission. An online calculator is provided here. CONCLUSIONS: Postpartum readmission for hypertension and pre-eclampsia may be accurately predicted but further model validation is needed. Model updating using data from multiple sites will be needed before use across clinical settings.
引用
- Venkatesh KK, Jelovsek JE, Hoffman M, et al. Postpartum readmission for hypertension and pre-eclampsia: development and validation of a predictive model. BJOG. 2023. PMID: 37317035. doi:10.1111/1471-0528.17572
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。